To provide a comprehensive assessment of immunotherapeutic responses fueled by CDK4/6 inhibitor and anti-PD-1 treatment, RNA-sequencing of murine tumor specimens was performed and analyzed. The gene discussed is PDCD1; the disease is neoplasm.